167 related articles for article (PubMed ID: 30258071)
1. TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9.
Wang G; Huang W; Li W; Chen S; Chen W; Zhou Y; Peng P; Gu W
Sci Rep; 2018 Sep; 8(1):14402. PubMed ID: 30258071
[TBL] [Abstract][Full Text] [Related]
2. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
[TBL] [Abstract][Full Text] [Related]
3. Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells.
Wang G; Zeng Y; Chen S; Li D; Li W; Zhou Y; Singer RH; Gu W
Sci Rep; 2017 Oct; 7(1):13575. PubMed ID: 29051606
[TBL] [Abstract][Full Text] [Related]
4. Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2.
Peng X; Li F; Wang P; Jia S; Sun L; Huo H
Int J Mol Med; 2015 Sep; 36(3):733-8. PubMed ID: 26135903
[TBL] [Abstract][Full Text] [Related]
5. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
6. Oldenlandia diffusa suppresses metastatic potential through inhibiting matrix metalloproteinase-9 and intercellular adhesion molecule-1 expression via p38 and ERK1/2 MAPK pathways and induces apoptosis in human breast cancer MCF-7 cells.
Chung TW; Choi H; Lee JM; Ha SH; Kwak CH; Abekura F; Park JY; Chang YC; Ha KT; Cho SH; Chang HW; Lee YC; Kim CH
J Ethnopharmacol; 2017 Jan; 195():309-317. PubMed ID: 27876502
[TBL] [Abstract][Full Text] [Related]
7. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.
Kim K; Madak-Erdogan Z; Ventrella R; Katzenellenbogen BS
Horm Cancer; 2013 Apr; 4(2):78-91. PubMed ID: 23250869
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
[TBL] [Abstract][Full Text] [Related]
9. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
10. SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.
You K; Su F; Liu L; Lv X; Zhang J; Zhang Y; Liu B
Mol Cell Biochem; 2017 Nov; 435(1-2):47-58. PubMed ID: 28497372
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
12. MFAP5 promotes tumor progression and bone metastasis by regulating ERK/MMP signaling pathways in breast cancer.
Wu Z; Wang T; Fang M; Huang W; Sun Z; Xiao J; Yan W
Biochem Biophys Res Commun; 2018 Apr; 498(3):495-501. PubMed ID: 29526753
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells.
Guo H; Lin Y; Zhang H; Liu J; Zhang N; Li Y; Kong D; Tang Q; Ma D
BMC Mol Biol; 2007 Dec; 8():110. PubMed ID: 18053161
[TBL] [Abstract][Full Text] [Related]
14. Functional role of alpha-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells.
Guvakova MA; Adams JC; Boettiger D
J Cell Sci; 2002 Nov; 115(Pt 21):4149-65. PubMed ID: 12356918
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
16. PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with α-actinin.
Liu Z; Zhan Y; Tu Y; Chen K; Liu Z; Wu C
Oncogene; 2015 Mar; 34(10):1300-11. PubMed ID: 24662836
[TBL] [Abstract][Full Text] [Related]
17. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
18. Targeting Mechanoresponsive Proteins in Pancreatic Cancer: 4-Hydroxyacetophenone Blocks Dissemination and Invasion by Activating MYH14.
Surcel A; Schiffhauer ES; Thomas DG; Zhu Q; DiNapoli KT; Herbig M; Otto O; West-Foyle H; Jacobi A; Kräter M; Plak K; Guck J; Jaffee EM; Iglesias PA; Anders RA; Robinson DN
Cancer Res; 2019 Sep; 79(18):4665-4678. PubMed ID: 31358530
[TBL] [Abstract][Full Text] [Related]
19. CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.
Bretz N; Noske A; Keller S; Erbe-Hofmann N; Schlange T; Salnikov AV; Moldenhauer G; Kristiansen G; Altevogt P
Clin Exp Metastasis; 2012 Jan; 29(1):27-38. PubMed ID: 21984372
[TBL] [Abstract][Full Text] [Related]
20. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.
Glading A; Koziol JA; Krueger J; Ginsberg MH
Cancer Res; 2007 Feb; 67(4):1536-44. PubMed ID: 17308092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
